Veen SJ - Search Results

1

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

De Wachter E, De Boeck K, Sermet-Gaudelus I, Simmonds NJ, Munck A, Naehrlich L, Barben J, Boyd C, Veen SJ, Carr SB, Fajac I, Farrell PM, Girodon E, Gonska T, Grody WW, Jain M, Jung A, Kerem E, Raraigh KS, van Koningsbruggen-Rietschel S, Waller MD, Southern KW, Castellani C; ECFS Diagnostic Network Working Group. De Wachter E, et al. Among authors: veen sj. J Cyst Fibros. 2024 Feb 21:S1569-1993(24)00011-0. doi: 10.1016/j.jcf.2024.01.012. Online ahead of print. J Cyst Fibros. 2024. PMID: 38388234

2

Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine Levels.

van der Veen SJ, Sayed ME, Hollak CEM, Brands MM, Snelder CKS, Boekholdt SM, Vogt L, Goorden SMI, van Kuilenburg ABP, Langeveld M. van der Veen SJ, et al. Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1272-1282. doi: 10.2215/CJN.0000000000000239. Epub 2023 Jul 27. Clin J Am Soc Nephrol. 2023. PMID: 37499686

3

Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don't.

van der Veen SJ, Langeveld M. van der Veen SJ, et al. Mol Ther Methods Clin Dev. 2022 Oct 29;27:324-326. doi: 10.1016/j.omtm.2022.10.007. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36381299 Free PMC article. No abstract available.

4

Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression.

van der Veen SJ, Körver S, Hirsch A, Hollak CEM, Wijburg FA, Brands MM, Tøndel C, van Kuilenburg ABP, Langeveld M. van der Veen SJ, et al. Mol Genet Metab. 2022 Feb;135(2):163-169. doi: 10.1016/j.ymgme.2021.12.004. Epub 2021 Dec 17. Mol Genet Metab. 2022. PMID: 35033446 Free article.

5

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.

van der Veen SJ, Vlietstra WJ, van Dussen L, van Kuilenburg ABP, Dijkgraaf MGW, Lenders M, Brand E, Wanner C, Hughes D, Elliott PM, Hollak CEM, Langeveld M. van der Veen SJ, et al. Int J Mol Sci. 2020 Aug 12;21(16):5784. doi: 10.3390/ijms21165784. Int J Mol Sci. 2020. PMID: 32806627 Free PMC article.

6

Developments in the treatment of Fabry disease.

van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. van der Veen SJ, et al. J Inherit Metab Dis. 2020 Sep;43(5):908-921. doi: 10.1002/jimd.12228. Epub 2020 Mar 2. J Inherit Metab Dis. 2020. PMID: 32083331 Free PMC article. Review.

7

Enhanced pulmonary uptake on ¹⁸F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

Venema CM, de Vries EFJ, van der Veen SJ, Dorrius MD, van Kruchten M, Schröder CP, Hospers GAP, Glaudemans AWJM. Venema CM, et al. Among authors: van der veen sj. EJNMMI Res. 2019 Aug 23;9(1):82. doi: 10.1186/s13550-019-0549-y. EJNMMI Res. 2019. PMID: 31444658 Free PMC article.

8

Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment.

van der Veen SJ, van Kuilenburg ABP, Hollak CEM, Kaijen PHP, Voorberg J, Langeveld M. van der Veen SJ, et al. Mol Genet Metab. 2019 Feb;126(2):162-168. doi: 10.1016/j.ymgme.2018.11.008. Epub 2018 Nov 17. Mol Genet Metab. 2019. PMID: 30473480

9

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.

Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC. Sio TT, et al. Among authors: van der veen sj. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):686-696. doi: 10.1016/j.ijrobp.2018.10.035. Epub 2018 Nov 2. Int J Radiat Oncol Biol Phys. 2019. PMID: 30395904 Free PMC article. Clinical Trial.

10

Revealing and Quantifying the Three-Dimensional Nano- and Microscale Structures in Self-Assembled Cellulose Microfibrils in Dispersions.

Mohan S, Jose J, Kuijk A, Veen SJ, van Blaaderen A, Velikov KP. Mohan S, et al. Among authors: veen sj. ACS Omega. 2017 Aug 31;2(8):5019-5024. doi: 10.1021/acsomega.7b00536. Epub 2017 Aug 28. ACS Omega. 2017. PMID: 30023735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page